Moore AL - Search Results

1

Nitric oxide modulates lymphocyte proliferation but not secretion of IL-2.

Huot AE, Moore AL, Roberts JD, Hacker MP. Huot AE, et al. Among authors: moore al. Immunol Invest. 1993 Jun;22(4):319-27. doi: 10.3109/08820139309063411. Immunol Invest. 1993. PMID: 7689536

2

Increased systemic, but not regional, neopterin production following intraperitoneal administration of interleukin-2 and lack of effect of pterins upon the lymphokine-activated killer cell phenomenon.

Roberts JD, Bigelow JC, Moore AL, Belinson JL, Stewart JA, Hacker MP. Roberts JD, et al. Among authors: moore al. J Immunother Emphasis Tumor Immunol. 1994 Jan;15(1):53-8. doi: 10.1097/00002371-199401000-00007. J Immunother Emphasis Tumor Immunol. 1994. PMID: 8110731

3

Specific antibody synthesis in vitro. I. Technical considerations.

Moore AL, Ershler WB, Hacker MP. Moore AL, et al. J Immunol Methods. 1984 May 11;70(1):13-21. doi: 10.1016/0022-1759(84)90384-3. J Immunol Methods. 1984. PMID: 6609208

4

Phase I trial of intraperitoneal recombinant interleukin-2/lymphokine-activated killer cells in patients with ovarian cancer.

Stewart JA, Belinson JL, Moore AL, Dorighi JA, Grant BW, Haugh LD, Roberts JD, Albertini RJ, Branda RF. Stewart JA, et al. Among authors: moore al. Cancer Res. 1990 Oct 1;50(19):6302-10. Cancer Res. 1990. PMID: 2205379 Clinical Trial.

5

Specific antibody synthesis in vitro. II. Age-associated thymosin enhancement of antitetanus antibody synthesis.

Ershler WB, Moore AL, Hacker MP, Ninomiya J, Naylor P, Goldstein AL. Ershler WB, et al. Among authors: moore al. Immunopharmacology. 1984 Oct;8(2):69-77. doi: 10.1016/0162-3109(84)90045-6. Immunopharmacology. 1984. PMID: 6511366

6

Cimetidine and the immune response. I. In vivo augmentation of nonspecific and specific immune response.

Ershler WB, Hacker MP, Burroughs BJ, Moore AL, Myers CF. Ershler WB, et al. Among authors: moore al. Clin Immunol Immunopathol. 1983 Jan;26(1):10-7. doi: 10.1016/0090-1229(83)90168-x. Clin Immunol Immunopathol. 1983. PMID: 6872335

7

Specific in vivo and in vitro antibody response to tetanus toxoid immunization.

Ershler WB, Moore AL, Hacker MP. Ershler WB, et al. Among authors: moore al. Clin Exp Immunol. 1982 Sep;49(3):552-8. Clin Exp Immunol. 1982. PMID: 6756720 Free PMC article.

8

Experimental tumors and aging: local factors that may account for the observed age advantage in the B16 murine melanoma model.

Ershler WB, Gamelli RL, Moore AL, Hacker MP, Blow AJ. Ershler WB, et al. Among authors: moore al. Exp Gerontol. 1984;19(6):367-76. doi: 10.1016/0531-5565(84)90046-9. Exp Gerontol. 1984. PMID: 6519208

9

Tumor vasculature in young and old hosts: scanning electron microscopy of microcorrosion casts with microangiography, light microscopy and transmission electron microscopy.

Walmsley JG, Granter SR, Hacker MP, Moore AL, Ershler WB. Walmsley JG, et al. Among authors: moore al. Scanning Microsc. 1987 Jun;1(2):823-30. Scanning Microsc. 1987. PMID: 2441463

10

B16 murine melanoma and aging: slower growth and longer survival in old mice.

Ershler WB, Stewart JA, Hacker MP, Moore AL, Tindle BH. Ershler WB, et al. Among authors: moore al. J Natl Cancer Inst. 1984 Jan;72(1):161-4. doi: 10.1093/jnci/72.1.161. J Natl Cancer Inst. 1984. PMID: 6582296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

406 results

Search Page

Filters